MMSI Announces Commencement of Patient Enrollment in PREEMIE Study
Portfolio Pulse from
Merit Medical Systems, Inc. (MMSI) has started enrolling patients in the PREEMIE study to evaluate the Bloom Micro Occluder System's safety and efficacy for treating patent ductus arteriosus (PDA) in premature infants.
March 14, 2025 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical Systems has initiated patient enrollment in the PREEMIE study to assess the Bloom Micro Occluder System for PDA treatment in premature infants, potentially impacting future product offerings and market position.
The commencement of the PREEMIE study by MMSI is a significant step in potentially expanding their product offerings in the pediatric medical device market. Successful results could enhance their market position and drive future revenue growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100